ISSN : 3023-7505
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Automated Perimetry
Carbonic Anhydrase Inhibitors
Intra Ocular Lens Power Calculation and Optic Biometry...
Visual Field Defects in Glaucoma
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Current Minimal Invasive Angle Procedures Without Implants for the Treatment of Glaucoma...
Intra Ocular Lens Power Calculation and Optic Biometry...
Automated Perimetry
Carbonic Anhydrase Inhibitors
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
PureSee Kesintisiz Yüksek Kalitede Görüş
TJ-CEO 2011 , Vol 6 , Num 3
Turkish Abstract Abstract PDF Similar Articles Mail to Author
The Effects of Latanoprost on Corneal Thickness, Endothelial Cell Density, Topography; Anterior Chamber Depth and Axial Length
Çiğdem ALTAN1, Hülya GÜNGEL2, Deniz OYGAR BAYLANÇIÇEK3, Işılay ÖZDEMİR KAVADARLI4, Mümin Hakan EREN1
1Beyoğlu Göz Eğitim ve Araştırma Hastanesi, İstanbul, Uzm. Dr.
2Beyoğlu Göz Eğitim ve Araştırma Hastanesi, İstanbul, Prof. Dr.
3Serbest hekim, İstanbul, Uz. Dr.
4Kilis Devlet Hastanesi, Gaziantep, Uz. Dr.
Purpose: Latanoprost has effects on extracellular matrix and collagen metabolism in the ciliary body. The same mechanisms probably act in cornea, zonula fibers and sclera. The aim of the current study was to analyze the clinical visible effects latanoprost on axial length (AL), anterior chamber depth (ACD), corneal topography, endothelial cell density (ECD) and central corneal thickness (CCT).
Materials and Methods: Fifty-four eyes of 54 patients with newly diagnosed primary open angle glaucoma, normotensive glaucoma or ocular hypertension were included. Patients were examined before treatment and at the first, third and sixth month after latanoprost treatment. Visual acuity (VA), spheric equıvalent (SE), intraocular pressure (IOP), AL, ACD, corneal topography, ECD, and CCT were measured at each examination.
Results: Twenty-one males and 33 females with a mean age of 59.2±12.6 years were included in the study. The mean IOP which was 21.4±7.2 mmHg before therapy significantly decreased to 14.6±4.6 mmHg at the first month, 14.9±3.6 mmHg at the third month and 14.7±3.5 mmHg at the sixth month (p<0.001). A significant positive correlation was found between baseline IOP and IOP-lowering effect and a negative correlation was present between IOP-lowering effect and AL (p<0.05). No significant change in VA and SE was found after treatment. No significant change was observed in AL, ACD, ECD, and corneal topography parameters (p>0.05). A statistically significant reduction in CCT was observed within 6 months (p=0.03).
Conclusion: Although latanoprost 0.005% does not cause clinically detectable changes in corneal topography, ECD, ACD and AL, it only causes statistically significant reduction in central corneal thickness within 6 months of the treatment period. Further large-scale studies with longer follow-ups are needed to elucidate effects of latanoprost on ocular structures.
Keywords : Latanoprost, axial length, anterior chamber depth, corneal topography, endothelial cell density and central corneal thickness
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact